KBI Biopharma to Open $150 Million Commercial Manufacturing Facility in North Carolina

Set to be operational by the first quarter of 2022, the 140,000-ft2 facility will feature up to six 2000-L, single-use bioreactor systems along with additional harvest and purification equipment to produce up to 100 commercial batches annually.

KBI Biopharma, a JSR Life Sciences company, announced on Dec. 1, 2020 that it has opened a new $150 million commercial manufacturing facility in Research Triangle Park, NC.

Set to be operational by the first quarter of 2022, the 140,000-ft2 facility will feature up to six 2000-L, single-use bioreactor systems along with additional harvest and purification equipment to produce up to 100 commercial batches annually, a company press release said. The new site will also be equipped to provide accommodations for mammalian-based biologics manufacturing processes for KBI’s future and existing collaborators.

“Expansion of our US-based cell culture operations is a key investment to support our client’s commercialization strategies,” said KBI president and CEO Dirk Lange in the press release. “This state-of-the-art facility will leverage the latest innovation in automation and digitalization to best meet the needs for our clients.”

Source: KBI